These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35154451)

  • 1. Dynamic changes of platelets before and after surgery predict the prognosis of patients with operable non-small cell lung cancer.
    Yang W; Yao Y; Chen Y; Jin F; Zheng T; Ai X; Zhang T; Ding C; Jiang M
    J Cancer; 2022; 13(3):823-830. PubMed ID: 35154451
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and validation of postoperative and preoperative platelets ratio (PPR) to predict the prognosis of patients undergoing surgery for colorectal cancer: A dual-center retrospective cohort study.
    Yang W; Zheng X; Wu M; Zhang F; Xu S; Wang X; Song M; You C; Zhang T; Jiang M; Ding C
    Cancer Med; 2023 Jan; 12(1):111-121. PubMed ID: 35689440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
    Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
    J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of the preoperative platelet count and platelet-to-lymphocyte ratio (PLT-PLR) in patients with surgically resected non-small cell lung cancer.
    Kim SH; Lee HW; Go SI; Lee SI; Lee GW
    Oncotarget; 2016 Jun; 7(24):36198-36206. PubMed ID: 27105529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer.
    Gao L; Zhang H; Zhang B; Zhang L; Wang C
    Oncotarget; 2017 Feb; 8(9):15632-15641. PubMed ID: 28152504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Rho GTPase activating protein 9 combined with preoperative ratio of platelet distribution width to platelet count on prognosis of patients with serous ovarian cancer.
    Shen Y; Xu H; Guan Z; Lv M; Qian T; Wu Y
    Transl Cancer Res; 2021 Oct; 10(10):4440-4453. PubMed ID: 35116301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the prognosis of operable gastric cancer patients by dynamic changes in platelets before and after surgery: a retrospective cohort study.
    Li J; Yang X; Wang X; Jiang Y; Wang Z; Shen X; Li Z
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15479-15487. PubMed ID: 37642724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red blood cell distribution width and platelet counts are independent prognostic factors and improve the predictive ability of IPI score in diffuse large B-cell lymphoma patients.
    Li M; Xia H; Zheng H; Li Y; Liu J; Hu L; Li J; Ding Y; Pu L; Gui Q; Zheng Y; Zhai Z; Xiong S
    BMC Cancer; 2019 Nov; 19(1):1084. PubMed ID: 31711453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial.
    Trillsch F; Mahner S; Hilpert F; Davies L; García-Martínez E; Kristensen G; Savarese A; Vuylsteke P; Los M; Zagouri F; Gladieff L; Sehouli J; Khoon Lee C; Gebski V; Pujade-Lauraine E
    Ann Oncol; 2016 Sep; 27(9):1733-9. PubMed ID: 27287207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of preoperative platelet, fibrinogen, and D-dimer levels in patients with non-small cell lung cancer: A multicenter prospective study.
    Hou C; Jiang F; Ma H; Zhu Q; Wang Z; Zhao B; Xue T; Tan S; Yang R; Qian Y; Luo X; Zhao M; Xu X; Chen L; Li J
    Thorac Cancer; 2019 Feb; 10(2):304-311. PubMed ID: 30609303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic value of preoperative platelet parameters in locally advanced renal cell carcinoma].
    Xiao RT; Liu C; Xu CX; He W; Ma LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):647-652. PubMed ID: 34393222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
    Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
    Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
    Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
    Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COV is a readily available quantitative indicator of metabolic heterogeneity for predicting survival of patients with early and locally advanced NSCLC manifesting as central lung cancer.
    Yu T
    Eur J Radiol; 2020 Nov; 132():109338. PubMed ID: 33068840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of the SUVmax Measured From FDG PET and Neutrophil-to-lymphocyte Ratio Improves Prediction of Clinical Outcomes in Patients With Locally Advanced Non-small-cell Lung Cancer.
    Guo D; Jin F; Jing W; Li M; Chen D; Zou B; Jiang G; Fu L; Zhu H; Kong L; Wu J; Yu J; Yue J
    Clin Lung Cancer; 2019 Nov; 20(6):412-419. PubMed ID: 31300364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer.
    Jin F; Han A; Shi F; Kong L; Yu J
    Onco Targets Ther; 2016; 9():6529-6537. PubMed ID: 27799800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative increased systemic immune-inflammation index predicts poor prognosis in patients with operable non-small cell lung cancer.
    Gao Y; Zhang H; Li Y; Wang D; Ma Y; Chen Q
    Clin Chim Acta; 2018 Sep; 484():272-277. PubMed ID: 29860033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.